These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15685243)

  • 21. Notch signaling induces cell cycle arrest in small cell lung cancer cells.
    Sriuranpong V; Borges MW; Ravi RK; Arnold DR; Nelkin BD; Baylin SB; Ball DW
    Cancer Res; 2001 Apr; 61(7):3200-5. PubMed ID: 11306509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproic acid upregulates the expression of the p75NTR/sortilin receptor complex to induce neuronal apoptosis.
    Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
    Apoptosis; 2020 Oct; 25(9-10):697-714. PubMed ID: 32712736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.
    Farrelly LA; Savage NT; O'Callaghan C; Toulouse A; Yilmazer-Hanke DM
    Regul Pept; 2013 Sep; 186():123-30. PubMed ID: 23994577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy.
    Biran A; Brownstein M; Haklai R; Kloog Y
    Int J Cancer; 2011 Feb; 128(3):691-701. PubMed ID: 20473860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notch signaling is activated by TLR stimulation and regulates macrophage functions.
    Palaga T; Buranaruk C; Rengpipat S; Fauq AH; Golde TE; Kaufmann SH; Osborne BA
    Eur J Immunol; 2008 Jan; 38(1):174-83. PubMed ID: 18085664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase inhibitor Helminthosporium carbonum (HC)-toxin suppresses the malignant phenotype of neuroblastoma cells.
    Deubzer HE; Ehemann V; Westermann F; Heinrich R; Mechtersheimer G; Kulozik AE; Schwab M; Witt O
    Int J Cancer; 2008 Apr; 122(8):1891-900. PubMed ID: 18074352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
    Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
    Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
    Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors.
    Facchetti F; Previdi S; Ballarini M; Minucci S; Perego P; La Porta CA
    Apoptosis; 2004 Sep; 9(5):573-82. PubMed ID: 15314285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
    Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
    Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
    Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N
    BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
    Castro LM; Gallant M; Niles LP
    J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma.
    Gu S; Tian Y; Chlenski A; Salwen HR; Lu Z; Raj JU; Yang Q
    Anticancer Drugs; 2012 Nov; 23(10):1054-66. PubMed ID: 22863973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced neuroblastoma cell differentiation, associated with transient HES-1 activity and reduced HASH-1 expression, is inhibited by Notch1.
    Grynfeld A; Påhlman S; Axelson H
    Int J Cancer; 2000 Nov; 88(3):401-10. PubMed ID: 11054669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproic acid exhibits biphasic effects on apoptotic cell death of activated lymphocytes through differential modulation of multiple signaling pathways.
    Chen Q; Ouyang DY; Geng M; Xu LH; Zhang YT; Wang FP; He XH
    J Immunotoxicol; 2011; 8(3):210-8. PubMed ID: 21457087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
    Poljakova J; Hrebackova J; Dvorakova M; Moserova M; Eckschlager T; Hrabeta J; Göttlicherova M; Kopejtkova B; Frei E; Kizek R; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():101-16. PubMed ID: 22167207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eosinophilic differentiation is promoted by blockage of Notch signaling with a gamma-secretase inhibitor.
    Kang JH; Lee DH; Lee JS; Kim HJ; Shin JW; Lee YH; Lee YS; Park CS; Chung IY
    Eur J Immunol; 2005 Oct; 35(10):2982-90. PubMed ID: 16143988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
    Sung ES; Kim A; Park JS; Chung J; Kwon MH; Kim YS
    Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells.
    Cerna T; Hrabeta J; Eckschlager T; Frei E; Schmeiser HH; Arlt VM; Stiborová M
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29304031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain.
    Schroeter EH; Kisslinger JA; Kopan R
    Nature; 1998 May; 393(6683):382-6. PubMed ID: 9620803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.